FORCE

Genetic counselors and patient advocates say more people are refusing genetic testing because they're uncertain of how it will impact their insurance.

Women with a family history of breast and ovarian cancer who are interested in getting genetically tested to gauge whether they have a heightened risk for the diseases should speak to a genetic counselor before getting tested, patient groups are advising their members.

This article has been updated to correct that Ellen Matloff is a plaintiff in AMP v. USPTO.

At a SACGHS meeting last week, FORCE said that Myriad Genetics sales representatives discourage doctors from referring patients to genetic counselors, and recommended the committee make recommendations for greater monitoring of such actions. SACGHS plans to invite Myriad to respond to the allegations.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.